Figure 5c:

Images in a patient who had undergone radical prostatectomy (PSA level, 2.97 ng/mL). (a) Transverse PET and (b) fused PET/CT scans obtained with anti-3-¹⁸F-FACBC. (c) SPECT and (d) fused SPECT/CT scans obtained with ¹¹¹In–capromab pendetide. Intense uptake on images obtained with anti-3-¹⁸F-FACBC (arrow in a and b) corresponded to a subtle lytic bone lesion in the right pubic ramus, which was proved as recurrence at biopsy. There is no uptake in same region on images obtained with ¹¹¹In–capromab pendetide (arrow in c and d). This is an example of a true-positive finding with anti-3-¹⁸F-FACBC and a false-negative finding with ¹¹¹In–capromab pendetide.